Mardi 24

Rate this post

Mardi 24
16h – 17h 30 : Communications orales simultanées

Session 11 : Pharmacologie cardiovasculaire Salle LEOPOLD


Modérateurs :??? 1/ Cardiac performance is maintained in a rat model of aortic stiffness. Hubert S, Lartaud-Idjouadiene I, Lompré AM, Atkinson J. 119 2/ Effect of fasidotril, a mixed inhibitor of neutral endopeptidase and angiotensin I-converting enzyme, on survival of rats with myocardial infarction. Marie C, Mossiat C, Gros C, Schwartz JC, Lecomte JM, Bralet J. 120 3/ Effects of the selective ETa antagonist LU 135 252 on ventricular hemodynamics and remodeling in a rat model of chronic heart failure. Mulder P, Richard V, Henry JP, Münter K, Thuillez C. 121 4/ Myocardial post ganglionic sympathetic dysfunction detected with meta-[123 I] iodobenzylguanidine (MIBG) in parkinsonians with autonomic failure. Brefel-Courbon C, Courbon F, Alibelli MJ, Rascol O, Regis H, Montastruc JL, Senard JM. 122 5/ Analysis of heart rate variability after a single administration of S16257-2, a sino-atrial modulator agent, in healthy subjects. Nony P, Gignoux A, Delair S, Girard P, Dayoub G, Hazebroucq J, Lerebours G, Loge JY, Boissel JP. 123 6/ Pharmacokinetic-Pharmacodynamic modelling of the effects of S-16257, a direct sinus node modulator, on heart rate in healthy volunteers.

Ragueneau I, Laveille C, Jochemsen R, Weber C, Funck-Brentano C, Jaillon P. 124

Session 12 : Neuro pharmacologie Salle BOFFRAND


Modérateurs :??? 1/ Role of the dopamine D3 receptor in levodopa-induced behavioral sensitization in 6-OH-DA lesioned rats. Bordet R, Ridray S, Sokoloff P, Schwartz JC. 125 2/ Differences in the efficacy of dopamine D4 receptor ligands according to the expression system. Gazi L, Sommer B, Hoyer D, Tricklebank M, Schoeffter P. 126 3/ Characteristics of central 5-HT1A receptors in mice lacking the 5-HT transporter. Lanfumey L, Mannoury Lacour C, Rioux A, Fabre V, Martres MP, Lesch KP, Hamon M. 127 4/ Dose-dependent influence of buspirone on the activities of SSRI in the mouse forced swimming test. Bourin M, Redrobe P, Colombel MC, Baker GB. 128 5/ Melatonin improves cerebral circulation security margin. Regrigny O, Delagrange P, Scalbert E, Atkinson J, Lartaud-Idjoudiene. 129 6/ Effect of inhibition of neutrophil infiltration in inducible no-synthase expressionafter transient focal cerebral ischemia in rats.

Parmentier S, Margaill I, Boulu RG, Plotkine M. 130

Session 13 : Pharmacovigilance Salle GALLE


Modérateurs :??? 1/ L’association acide fusidique-pristinamycine peut-elle être responsable de neuropathies périphériques. Ratrema M, Antoine JC, Guy C, Beyens MN, Ferracin C, Pallot-Prades B, Lapras J, Michel D, Ollagnier M. 131 2/ Acute oxaliplatin neurotoxicity dramatically improved with intravenous calcium and magnesium salts. Lainé-Cessac P, Boisdron-Celle M, Girault C, Allain P, Gamelin E. 132 3/ Adverse drug reaction in hospitalized patients with psychiatric disorders :detection and cost analysis. Tazaroute M, Bordet R, Catteau J, Caron J, Parquet PJ. 133 4/ Cardiac adverse events related to 5 fluorouracil. A meta-analysis of randomized clinical trials. Lapeyre-Mestre M, Carhlant-Kowalski D, Cucherat M, Bugat R, Begaud B, Montastruc JL 134 5/ Evaluation de l’impact d’une lettre d’information sur le métoclopramide. Jean-Pastor MJ, Larida ME, Rodor F, Locatelli C, Gambini D, Nguyen N, Obedia E, Jouglard J. 135 6/ Evaluation de l’intérêt des tests cutanés médicamenteux dans l’exploration des toxidermies.

Barbaud A, Tréchot P, Reichert-Pénétrat S, Deneux A, Faure G, Béné MC, Schmutz JL. 136